A whale with a lot of money to spend has taken a noticeably bullish stance on DexCom.
Looking at options history for DexCom DXCM we detected 25 strange trades.
If we consider the specifics of each trade, it is accurate to state that 64% of the investors opened trades with bullish expectations and 36% with bearish.
From the overall spotted trades, 10 are puts, for a total amount of $1,000,229 and 15, calls, for a total amount of $663,409.
What's The Price Target?
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $60.0 to $150.0 for DexCom over the last 3 months.
Volume & Open Interest Development
In terms of liquidity and interest, the mean open interest for DexCom options trades today is 2267.53 with a total volume of 12,452.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for DexCom's big money trades within a strike price range of $60.0 to $150.0 over the last 30 days.
DexCom Option Volume And Open Interest Over Last 30 Days
Biggest Options Spotted:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|
| DXCM | PUT | TRADE | NEUTRAL | 01/19/24 | $85.00 | $232.5K | 110 | 0 |
| DXCM | PUT | TRADE | BULLISH | 02/16/24 | $85.00 | $210.0K | 2.4K | 206 |
| DXCM | PUT | SWEEP | BEARISH | 12/15/23 | $75.00 | $156.0K | 425 | 1.1K |
| DXCM | PUT | SWEEP | BULLISH | 11/17/23 | $90.00 | $141.1K | 810 | 147 |
| DXCM | PUT | SWEEP | BEARISH | 11/17/23 | $70.00 | $75.0K | 2.5K | 1.6K |
Where Is DexCom Standing Right Now?
- With a volume of 4,247,357, the price of DXCM is down -0.3% at $84.1.
- RSI indicators hint that the underlying stock may be approaching oversold.
- Next earnings are expected to be released in 0 days.
What The Experts Say On DexCom:
- JP Morgan has decided to maintain their Overweight rating on DexCom, which currently sits at a price target of $100.
- Morgan Stanley has decided to maintain their Equal-Weight rating on DexCom, which currently sits at a price target of $98.
- Leerink Partners downgraded its action to Outperform with a price target of $110
- Stifel has decided to maintain their Buy rating on DexCom, which currently sits at a price target of $145.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for DexCom, Benzinga Pro gives you real-time options trades alerts.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
